ESS vs EYPT · P/E 31, rev $489.0M vs rev $1.2M
Essex Property Trust Inc (ESS) versus Eyepoint Pharmaceuticals Inc (EYPT) — a side-by-side from cached financials, not a winner call.
Essex Property Trust Inc (ESS) is a reit - residential company listed on NYSE.
Eyepoint Pharmaceuticals Inc (EYPT) is a biotechnology company listed on NASDAQ.
Latest reported ESS revenue for 2026-06-30 was $489.0M. Net income was $66.9M. Revenue was up 0.9% from 2026-03-31 to 2026-06-30. ESS currently screens at market cap $18.91B and trailing P/E 30.9.
Latest reported EYPT revenue for 2026-06-30 was $1.2M. Net income was -$179.3M. Revenue was up 72.8% from 2026-03-31 to 2026-06-30. EYPT currently screens at market cap $1.10B.
ESS currently screens at market cap $18.91B and trailing P/E 30.9. EYPT currently screens at market cap $1.10B.
Not investment advice. Open the ESS and EYPT stock pages for the full models.
Not investment advice.